VANCOUVER, Oct. 16, 2012 /CNW/ - CRH Medical Corporation (TSX: CRH, OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it will release its financial results for the third quarter ended September 30, 2012, after the market close on Thursday, October 18, 2012. A telephone conference call hosted by management to discuss the quarter will be held:
Thursday, October 18, 2012 at 5:00 pm EST
The telephone numbers for the conference call are:
(888) 231-8191 or (647) 427-7450
At the call's completion, an audio replay will be available by calling (855) 859-2056 and using passcode 47908975. The phone replay will be available through November 1, 2012.
About CRH Medical Corporation:
CRH Medical Corporation is a North American company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is safe and highly effective in treating hemorrhoid grades I - IV. The O'Regan System is rapidly emerging as the standard of care with gastroenterologists who treat hemorrhoids. In addition to the product, CRH Medical delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its web-based platform to connect doctors with patients as well as educating its increasing install base of physicians.
SOURCE: CRH Medical Corporation
For further information:
Edward Wright, Chief Executive Officer
CRH Medical Corporation
Adam Peeler, Media and Investor Relations
416.815.0700 x 225